Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.

Xavier RoblinAdrian SeroneOh Kyu YoonLuting ZhuoEthan GrantJacky WooJinfeng LiuRené GalienGeert R A M D'Haens

Published in: Inflammatory bowel diseases (2021)

Several circulating factors with potential as CD activity biomarkers were identified. Larger studies are necessary to investigate the best utility of these markers for CD.

Keyphrases

nk cells
genome wide
dna methylation
climate change
case control
bioinformatics analysis
transcription factor
genome wide identification